PMID- 10088552 OWN - NLM STAT- MEDLINE DCOM- 19990401 LR - 20190722 IS - 0046-8177 (Print) IS - 0046-8177 (Linking) VI - 30 IP - 3 DP - 1999 Mar TI - Detection of EWS-FLI-1 fusion in Ewing's sarcoma/peripheral primitive neuroectodermal tumor by fluorescence in situ hybridization using formalin-fixed paraffin-embedded tissue. PG - 324-30 AB - The balanced translocation t(11;22)(q24;q12) is specific for the Ewing's sarcoma/peripheral primitive neuroectodermal tumors (ES/PNETs) and results in the EWS/FLI-1 fusion transcript, which can be detected by reverse transcription polymerase chain reaction (RT-PCR). Recent studies also have used fluorescence in situ hybridization (FISH) to show the translocation; however, most of these have been performed on cell lines or touch preparations and short-term cultures of tumors. Moreover, the existing probes generally have shown only the break in the specific chromosomes rather than the translocation itself. We describe our findings with a new set of probes that localize to 22q12 (EWS) and 11q24 (FLI-1) and directly show the translocation as juxtaposed red-green signals on der(22) in nuclei extracted from formalin-fixed, paraffm-embedded tissues. After establishing the specificity of the probes (on metaphase spreads and interphase nuclei in two translocation-positive cell lines and normal peripheral blood lymphocytes), we evaluated 11 ES/PNETs and 10 other tumors (four alveolar rhabdomyosarcomas, three neuroblastomas, two lymphomas, one extramedullary myeloid tumor) using a two-color FISH assay. All 11 ES/PNETs showed fusion signals in 20% to 80% of evaluable nuclei. In two lymphoma cases, random overlapping signals were present in 2% and 4% of nuclei, whereas the remaining eight tumors were negative. The presence of t(11;22) was confirmed by RT-PCR in 10 of 11 ES/PNETs. We conclude that FISH analysis with this newly designed probe pair is a specific and sensitive method of detecting t(11;22) on routinely processed tissue and can be useful in the differential diagnosis of ES/PNETs from other small round blue cell tumors when only fixed tissue is available. FAU - Kumar, S AU - Kumar S AD - Laboratory of Pathology, National Cancer Institute, and Cancer Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892-1500, USA. FAU - Pack, S AU - Pack S FAU - Kumar, D AU - Kumar D FAU - Walker, R AU - Walker R FAU - Quezado, M AU - Quezado M FAU - Zhuang, Z AU - Zhuang Z FAU - Meltzer, P AU - Meltzer P FAU - Tsokos, M AU - Tsokos M LA - eng PT - Journal Article PL - United States TA - Hum Pathol JT - Human pathology JID - 9421547 RN - 0 (EWS-FLI fusion protein) RN - 0 (Oncogene Proteins, Fusion) RN - 0 (Proto-Oncogene Protein c-fli-1) RN - 0 (RNA-Binding Protein EWS) RN - 0 (Transcription Factors) RN - 1HG84L3525 (Formaldehyde) SB - IM MH - Adolescent MH - Adult MH - Child MH - Female MH - Formaldehyde MH - Humans MH - In Situ Hybridization, Fluorescence MH - Male MH - Neuroectodermal Tumors, Primitive/*genetics/pathology MH - Oncogene Proteins, Fusion/*genetics MH - Paraffin Embedding MH - Proto-Oncogene Protein c-fli-1 MH - RNA-Binding Protein EWS MH - Reverse Transcriptase Polymerase Chain Reaction MH - Sarcoma, Ewing/*genetics/pathology MH - Transcription Factors/*genetics EDAT- 1999/03/24 00:00 MHDA- 1999/03/24 00:01 CRDT- 1999/03/24 00:00 PHST- 1999/03/24 00:00 [pubmed] PHST- 1999/03/24 00:01 [medline] PHST- 1999/03/24 00:00 [entrez] AID - S0046-8177(99)90012-6 [pii] AID - 10.1016/s0046-8177(99)90012-6 [doi] PST - ppublish SO - Hum Pathol. 1999 Mar;30(3):324-30. doi: 10.1016/s0046-8177(99)90012-6.